Headlines about Validus (NYSE:VR) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Validus earned a news impact score of 0.16 on Accern’s scale. Accern also gave news headlines about the insurance provider an impact score of 46.4081082669202 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the headlines that may have impacted Accern’s analysis:
Several analysts have weighed in on the company. Barclays decreased their price objective on Validus from $57.00 to $53.00 and set an “equal weight” rating for the company in a report on Monday, October 16th. ValuEngine cut Validus from a “buy” rating to a “hold” rating in a report on Wednesday, October 11th. Zacks Investment Research cut Validus from a “hold” rating to a “sell” rating in a report on Saturday, January 13th. Keefe, Bruyette & Woods reissued a “hold” rating and issued a $51.00 price objective on shares of Validus in a report on Thursday, October 12th. Finally, UBS Group upped their price target on Validus from $48.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, October 30th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company’s stock. Validus has a consensus rating of “Hold” and a consensus price target of $52.80.
Shares of Validus (VR) traded down $0.07 during trading on Monday, hitting $67.44. The company’s stock had a trading volume of 3,268,720 shares, compared to its average volume of 2,945,163. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $5,523.45, a PE ratio of -78.42, a P/E/G ratio of 1.81 and a beta of 1.05. Validus has a fifty-two week low of $41.15 and a fifty-two week high of $67.73.
Validus (NYSE:VR) last issued its quarterly earnings data on Thursday, February 1st. The insurance provider reported $0.05 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($1.00). The business had revenue of $346.88 million during the quarter, compared to analysts’ expectations of $352.00 million. Validus had a negative return on equity of 1.79% and a negative net margin of 1.70%. The company’s revenue was up 16.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.80 earnings per share. equities analysts forecast that Validus will post 4.13 EPS for the current fiscal year.
In related news, President Kean Driscoll sold 6,875 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $46.16, for a total value of $317,350.00. Following the completion of the transaction, the president now directly owns 110,858 shares in the company, valued at $5,117,205.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold 20,625 shares of company stock valued at $984,775 over the last quarter. 2.33% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION NOTICE: “Validus (VR) Given Daily Media Sentiment Score of 0.16” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/05/validus-vr-receives-daily-media-sentiment-score-of-0-16.html.
Validus Company Profile
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.